series-a
Stage
1
Investors
About
Replicate Bioscience is developing self-replicating RNA (srRNA) vaccine candidates and platform technologies targeting infectious diseases, including tuberculosis, HIV, and malaria.
Explore Replicate Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.